Literature DB >> 18547653

Expression and regulation of matrix metalloproteinase-12 in experimental autoimmune encephalomyelitis and by bone marrow derived macrophages in vitro.

Angelika Goncalves Dasilva1, V Wee Yong.   

Abstract

Several matrix metalloproteinase (MMP) members contribute to pathology in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). As the role of MMP-12 in EAE has been understudied, we examined its expression in EAE and in vitro. MMP-12 transcripts increased with EAE, and protein was localized to a subset of macrophages/microglia. The temporal expression of MMP-12 largely corresponded to that of cytokines, and we demonstrate that IL-1beta and TNF-alpha promoted MMP-12 expression in cultured macrophages. We postulate that cytokine - MMP-12 interactions are important in the disease process of EAE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547653     DOI: 10.1016/j.jneuroim.2008.04.034

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  14 in total

Review 1.  The role of matrix metalloproteinases in cystic fibrosis lung disease.

Authors:  A Gaggar; A Hector; P E Bratcher; M A Mall; M Griese; D Hartl
Journal:  Eur Respir J       Date:  2011-01-13       Impact factor: 16.671

2.  Cleavage of osteopontin by matrix metalloproteinase-12 modulates experimental autoimmune encephalomyelitis disease in C57BL/6 mice.

Authors:  Angelika Goncalves DaSilva; Lucy Liaw; V Wee Yong
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

3.  Analysis of the mitochondrial proteome in multiple sclerosis cortex.

Authors:  Laurie Broadwater; Ashish Pandit; Robert Clements; Sausan Azzam; Jonathan Vadnal; Michael Sulak; V Wee Yong; Ernest J Freeman; Roger B Gregory; Jennifer McDonough
Journal:  Biochim Biophys Acta       Date:  2011-02-02

4.  IL-23 modulated myelin-specific T cells induce EAE via an IFNγ driven, IL-17 independent pathway.

Authors:  Mark A Kroenke; Benjamin M Segal
Journal:  Brain Behav Immun       Date:  2010-10-15       Impact factor: 7.217

5.  Matrix metalloproteinase-12 deficiency worsens relapsing-remitting experimental autoimmune encephalomyelitis in association with cytokine and chemokine dysregulation.

Authors:  Angelika Goncalves DaSilva; V Wee Yong
Journal:  Am J Pathol       Date:  2009-02-13       Impact factor: 4.307

6.  Inflammatory proprotein convertase-matrix metalloproteinase proteolytic pathway in antigen-presenting cells as a step to autoimmune multiple sclerosis.

Authors:  Sergey A Shiryaev; Albert G Remacle; Alexei Y Savinov; Andrei V Chernov; Piotr Cieplak; Ilian A Radichev; Roy Williams; Tatiana N Shiryaeva; Katarzyna Gawlik; Tatiana I Postnova; Boris I Ratnikov; Alexei M Eroshkin; Khatereh Motamedchaboki; Jeffrey W Smith; Alex Y Strongin
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

7.  Regulation of progranulin expression in human microglia and proteolysis of progranulin by matrix metalloproteinase-12 (MMP-12).

Authors:  Hyeon-Sook Suh; Namjong Choi; Leonid Tarassishin; Sunhee C Lee
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

8.  A SELDI mass spectrometry study of experimental autoimmune encephalomyelitis: sample preparation, reproducibility, and differential protein expression patterns.

Authors:  Sausan Azzam; Laurie Broadwater; Shuo Li; Ernest J Freeman; Jennifer McDonough; Roger B Gregory
Journal:  Proteome Sci       Date:  2013-05-01       Impact factor: 2.480

9.  Matrix metalloproteinase proteolysis of the myelin basic protein isoforms is a source of immunogenic peptides in autoimmune multiple sclerosis.

Authors:  Sergey A Shiryaev; Alexei Y Savinov; Piotr Cieplak; Boris I Ratnikov; Khatereh Motamedchaboki; Jeffrey W Smith; Alex Y Strongin
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

Review 10.  Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.

Authors:  Viktoria Gudi; Stefan Gingele; Thomas Skripuletz; Martin Stangel
Journal:  Front Cell Neurosci       Date:  2014-03-13       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.